blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0445255

EP0445255 - USE OF HYALURONIC ACID IN COMBINATION WITH ASCORBIC ACID, ANTITUMOUR AGENTS AND/OR NSAIDs FOR TREATING CANCER [Right-click to bookmark this link]
Former [1991/37]TREATMENT OF CONDITIONS AND DISEASE
[2001/35]
StatusPatent maintained as amended
Status updated on  19.10.2001
Database last updated on 02.09.2024
Most recent event   Tooltip19.10.2001Patent maintained (B2 publication)published on 05.12.2001 [2001/49]
19.10.2001Change - miscellaneouspublished on 05.12.2001 [2001/49]
Applicant(s)For all designated states
JAGOTEC AG
Eptingerstrasse 51
4132 Muttenz / CH
[2000/46]
Former [2000/35]For all designated states
JAGOTEC AG
Seestrasse 47
CH-6052 Hergiswil NW / CH
Former [1994/52]For all designated states
HYAL PHARMACEUTICAL CORPORATION
8 King Street East Suite 1300
Toronto Ontario M5C 1B5 / CA
Former [1991/37]For all designated states
NORPHARMCO INC.
700 Bay Street, 20th Floor
Toronto, Ontario M5G 1Z6 / CA
Inventor(s)01 / FALK, Rudolf, Edgar
57 Rose Park Drive
Toronto, Ontario M4T 1R2 / CA
02 / ASCULAI, Samuel, S.
53 McCaul Street
Apt. 252 Toronto, Ontario M6M 2B6 / CA
[1991/37]
Representative(s)Bassil, Nicholas Charles, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[N/P]
Former [2000/32]Bassil, Nicholas Charles, et al
Kilburn & Strode 20 Red Lion Street
London WC1R 4PJ / GB
Former [1991/37]Cropp, John Anthony David, et al
MATHYS & SQUIRE 100 Grays Inn Road
London, WC1X 8AL / GB
Application number, filing date90914108.718.09.1990
[1991/37]
WO1990CA00306
Priority number, dateCA1989061230721.09.1989         Original published format: CA 612307
[1991/37]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9104058
Date:04.04.1991
Language:EN
[1991/08]
Type: A1 Application with search report 
No.:EP0445255
Date:11.09.1991
Language:EN
The application published by WIPO in one of the EPO official languages on 04.04.1991 takes the place of the publication of the European patent application.
[1991/37]
Type: B1 Patent specification 
No.:EP0445255
Date:06.12.1995
Language:EN
[1995/49]
Type: B2 New European patent specification 
No.:EP0445255
Date:05.12.2001
Language:EN
[2001/49]
Search report(s)International search report - published on:EP04.04.1991
ClassificationIPC:A61K47/36, A61P35/00
[2001/35]
CPC:
A61K9/0019 (EP,US); A61K47/36 (EP,KR,US); A61K31/10 (EP,US);
A61K31/13 (EP,US); A61K31/19 (EP,US); A61K31/192 (EP,US);
A61K31/195 (EP,US); A61K31/196 (EP,US); A61K31/375 (EP,US);
A61K31/40 (EP,US); A61K31/405 (EP,US); A61K31/407 (EP,US);
A61K31/44 (EP,US); A61K31/503 (EP,US); A61K31/54 (EP,US);
A61K31/5415 (EP,US); A61K31/616 (EP,US); A61K31/715 (EP,US);
A61K31/728 (EP,US); A61K45/06 (EP,US); A61K47/61 (EP,US);
A61K9/0014 (EP,US); A61P11/08 (EP); A61P17/00 (EP);
A61P29/00 (EP); A61P3/00 (EP); A61P31/00 (EP);
A61P35/00 (EP); A61P37/00 (EP); A61P5/24 (EP);
A61P7/10 (EP); A61P9/00 (EP) (-)
C-Set:
A61K31/715, A61K2300/00 (US,EP);
A61K31/728, A61K2300/00 (EP,US)
Former IPC [1991/37]A61K47/36
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   IT,   LI,   LU,   NL,   SE [1991/37]
TitleGerman:VERWENDUNG VON HYALURONSÄURE IN KOMBINATION MIT ASCORBINSÄURE, ANTITUMORMITTELN UND/ODER NSAIDs ZUR BEHANDLUNG VON KREBS[2001/35]
English:USE OF HYALURONIC ACID IN COMBINATION WITH ASCORBIC ACID, ANTITUMOUR AGENTS AND/OR NSAIDs FOR TREATING CANCER[2001/35]
French:UTILISATION DE L'ACIDE HYALURONIQUE EN COMBINAISON AVEC DE L'ACIDE ASCORBIQUE, DES AGENTS ANTUMUMORAUX ET/OU DES AINS POUR LE TRAITEMENT DU CANCER[2001/35]
Former [1991/37]BEHANDLUNG VON PATHOLOGISCHEN ZUSTÄNDEN UND KRANKHEITEN
Former [1991/37]TREATMENT OF CONDITIONS AND DISEASE
Former [1991/37]TRAITEMENT DE MALADIES ET D'ETATS PATHOLOGIQUES
MiscellaneousEPB 2001/49: (deleted)
EPB 2001/49: (deleted)
EPB 2001/49: (deleted)
EPB 1995/49: Teilanmeldung 95100186.6 eingereicht am 18/09/90
EPB 1995/49: Divisional application 95100186.6 filed on 18/09/90
EPB 1995/49: Demande divisionnaire 95100186.6 déposée le 18/09/90
Entry into regional phase22.05.1991National basic fee paid 
22.05.1991Designation fee(s) paid 
22.05.1991Examination fee paid 
Examination procedure22.05.1991Examination requested  [1991/37]
13.04.1992Despatch of a communication from the examining division (Time limit: M08)
15.12.1992Reply to a communication from the examining division
11.02.1993Despatch of a communication from the examining division (Time limit: M07)
21.09.1993Reply to a communication from the examining division
15.07.1994Despatch of communication of intention to grant (Approval: No)
21.02.1995Despatch of communication of intention to grant (Approval: later approval)
02.03.1995Communication of intention to grant the patent
21.04.1995Fee for grant paid
21.04.1995Fee for publishing/printing paid
Divisional application(s)EP95100186.6  / EP0656213
Opposition(s)Opponent(s)01  06.09.1996  08.10.1996  ADMISSIBLE
Gedeon Richter Ltd.
Gyömroi ut 19-21
1045 Budapest X / HU
Opponent's representative
Szabo, George S.A.
3 Oaklands Argyle Road
London, W13 0HG / GB
 02  06.09.1996  08.10.1996  ADMISSIBLE
FIDIA, S.p.A.
Via Ponte della Fabbrica 3-A
35031 ABANO TERME (Padova) / IT
Opponent's representative
Daniels, Jeffrey Nicholas, et al, et al
Page White & Farrer Limited
Bedford House
21A John Street
London WC1N 2BF / GB
 [N/P]
Former [1999/30]
Opponent(s)01  06.09.1996  08.10.1996  ADMISSIBLE
Gedeon Richter Ltd.
Gyömroi ut 19-21
1045 Budapest X / HU
Opponent's representative
Szabo, George S.A.
39 Wycherley Crescent
Barnet, Herts. EN5 1AP / GB
 02  06.09.1996  08.10.1996  ADMISSIBLE
FIDIA, S.p.A.
Via Ponte della Fabbrica 3-A
35031 ABANO TERME (Padova) / IT
Opponent's representative
Daniels, Jeffrey Nicholas, et al, et al
Page White & Farrer Bedford House John Street
London WC1N 2BF / GB
Former [1996/44]
Opponent(s)01  06.09.1996  08.10.1996  ADMISSIBLE
Gedeon Richter Ltd.
Gyömroi ut 19-21
1045 Budapest X / HU
Opponent's representative
Lord, Hilton David, et al, et al
Marks & Clerk LLP 90 Long Acre London
WC2E 9RA / GB
 02  06.09.1996  08.10.1996  ADMISSIBLE
FIDIA, S.p.A.
Via Ponte della Fabbrica 3-A
35031 ABANO TERME (Padova) / IT
Opponent's representative
Daniels, Jeffrey Nicholas, et al, et al
Page White & Farrer Bedford House John Street
London WC1N 2BF / GB
26.11.1996Invitation to proprietor to file observations on the notice of opposition
04.12.1997Reply of patent proprietor to notice(s) of opposition
25.06.1999Despatch of a communication from the opposition division (Time limit: M08)
01.03.2000Reply to a communication from the opposition division
06.03.2001Legal effect of interlocutory decision in opposition
06.03.2001Date of oral proceedings
27.03.2001Despatch of interlocutory decision in opposition
27.03.2001Despatch of minutes of oral proceedings
13.07.2001Despatch of communication that the patent will be maintained as amended
08.10.2001Fee for printing new specification paid
Fees paidRenewal fee
17.09.1992Renewal fee patent year 03
22.09.1993Renewal fee patent year 04
22.09.1994Renewal fee patent year 05
20.09.1995Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]JPS62240628  ;
 [X]EP0138572  (FIDIA SPA [IT]);
 [X]EP0197718  (FIDIA SPA [IT]);
 [X]EP0216453  (FIDIA SPA [IT]);
 [A]EP0224987  (BIOMATRIX INC [US]);
 [Y]EP0245126  (OGISO TARO [JP], et al);
 [A]US4711780  (FAHIM MOSTAFA S [US]);
 [X]EP0265116  (FIDIA SPA [IT]);
 [Y]EP0287210  (MEDICAL RESEARCH INT [GB]);
 [YP]EP0380367  (STAFFORD MILLER LTD [GB], et al)
 [Y]  - SNEADER W. E. ET AL, "Possible mechanism for the action of dimethyl sulfoxide on percutaneous absorption", CHEMICAL ABSTRACTS, (19720306), vol. 76, no. 10, Database accession no. 49897F, page 273
    [ ] - J. PHARM., PHAMACOL., (1971), vol. 23 SUPPL, page 252S
 [Y]  - DATABASE WPI, 1, Derwent World Patents Index, Database accession no. 87-337226, & JPS62240628 A 19871021 (KAO CORP.)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.